Debate: Is the FDA’s review process for GE animals fit for purpose?

To explore whether the regulatory process in question is fit for purpose, the Food & Drug Law Institute’s Food and Drug Policy Forum has published papers by those for and against GE animals, using AquaBounty Technologies’ experiences as a case study.

(AquaBounty  is seeking to gain approval for its genetically engineered AquAdvantage Atlantic salmon, which includes a gene from the faster-growing Pacific Chinook salmon enabling it to reach maturity twice as quickly as standard Atlantic salmon.)

In the red corner is Tim Schwab, senior researcher at anti-GM lobby group Food & Water Watch, who has penned the article: ‘Is FDA Ready to Regulate the World’s First Biotech Food Animal?’ (spoiler alert – he thinks ‘NO’). In the blue corner are Dr Alison L. Van Eenennaam, Dr William M. Muir, and Dr Eric M. Hallerman*, who have penned the response: ‘Is Unaccountable Regulatory Delay and Political Interference Undermining the FDA and Hurting American Competitiveness?’ (spoiler alert – they think ‘YES’)

Read the full story here:  GE salmon… Is the FDA’s review process for genetically engineered animals fit for purpose?

 

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
screenshot at  pm

Are pesticide residues on food something to worry about?

In 1962, Rachel Carson’s Silent Spring drew attention to pesticides and their possible dangers to humans, birds, mammals and the ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.